Oligohydramnios associated with administration of weekly paclitaxel for triple-negative breast cancer during pregnancy

被引：7
|
作者：
Shieh, M. P. [1 ]
Mehta, R. S. [1 ]
机构：
[1] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Div Hematol Oncol, Dept Med,Sch Med, Orange, CA 92668 USA
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷 / 09期
关键词：
D O I：
10.1093/annonc/mdr339
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2151 / U235
页数：2
相关论文
共 50 条
  • [1] Carboplatin-paclitaxel in triple-negative metastatic breast cancer during pregnancy with neoplastic thrombosis
    Monari, Francesca
    Grandi, Giovanni
    Guidotti, Isotta
    Torcetta, Francesco
    Battista, Rachele
    Coluccio, Valeria
    Piombino, Claudia
    Moscetti, Luca
    Neri, Isabella
    Toss, Angela
    MINERVA OBSTETRICS AND GYNECOLOGY, 2022, 74 (01) : 107 - 111
  • [2] Weekly Paclitaxel for Pregnancy Associated Breast Cancer
    Girardelli, Serena
    Bonomo, Barbara
    Papale, Margherita
    di Loreto, Eugenia
    Grossi, Elena
    Scarfone, Giovanna
    Rabaiotti, Emanuela
    Valsecchi, Luca
    Mangili, Giorgia
    Candiani, Massimo
    Peccatori, Fedro
    CLINICAL BREAST CANCER, 2024, 24 (03) : 199 - 203
  • [3] Breast Cancer During Pregnancy: A Marked Propensity to Triple-Negative Phenotype
    Allouch, Soumaya
    Gupta, Ishita
    Malik, Shaza
    Al Farsi, Halema F.
    Vranic, Semir
    Al Moustafa, Ala-Eddin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [4] A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy
    Liu, Yuetong
    Hong, Ge
    Mao, Lina
    Su, Zhe
    Liu, Tianjun
    Liu, Hong
    MOLECULES, 2023, 28 (09):
  • [5] MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer
    Oudin, Madeleine J.
    Barbier, Lucie
    Schafer, Claudia
    Kosciuk, Tatsiana
    Miller, Miles A.
    Han, Sangyoon
    Jonas, Oliver
    Lauffenburger, Douglas A.
    Gertler, Frank B.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (01) : 143 - 155
  • [6] Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer
    Hu, Xichun
    Xu, Binghe
    Cai, Li
    Wang, Zhonghua
    Wang, Biyun
    Zhang, Jian
    Teng, Yuee
    Tong, Zhongsheng
    Pan, Yueyin
    Yin, Yongmei
    Wu, Changping
    Jiang, Zefei
    Wang, Xiaojia
    Lou, Guyin
    Liu, Donggeng
    Feng, Jifeng
    Luo, Jianfeng
    Wu, Jiong
    Shao, Zhimin
    Ragaz, Joseph
    CANCER RESEARCH, 2015, 75
  • [7] Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer
    Ghebeh, Hazem
    Al-Sayed, Adher
    Eiada, Riham
    Cabangon, Leilani
    Ajarim, Dahish
    Suleman, Kausar
    Tulbah, Asma
    Al-Tweigeri, Taher
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer
    Hazem Ghebeh
    Adher Al-Sayed
    Riham Eiada
    Leilani Cabangon
    Dahish Ajarim
    Kausar Suleman
    Asma Tulbah
    Taher Al-Tweigeri
    Scientific Reports, 11
  • [9] Weekly ladiratuzumab vedotin monotherapy for metastatic triple-negative breast cancer
    Tsai, M.
    Han, H. S.
    Montero, A. J.
    Tkaczuk, K. H.
    Assad, H.
    Pusztai, L.
    Hurvitz, S. A.
    Wilks, S. T.
    Specht, J. M.
    Nanda, R.
    Mita, M.
    O'Shaughnessy, J.
    Krop, I. E.
    Medgyesy, D.
    Abraham, J.
    Modi, S.
    Li, H.
    Wu, S.
    Garfin, P. M.
    Burris, H. A., III
    ANNALS OF ONCOLOGY, 2021, 32 : S474 - S475
  • [10] Weekly vs Every-3-Week Carboplatin with Weekly Paclitaxel in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Retrospective Analysis
    Landry, Kara K.
    Lyon, Jessica L.
    Victoria, Kitty E.
    Changizzadeh, P. Nick
    Cole, Bernard F.
    Pulluri, Bhargavi
    Sikov, William M.
    Wood, Marie E.
    BREAST CANCER-TARGETS AND THERAPY, 2022, 14 : 63 - 70
12345